Coca-Cola (KO) Q1 2026 earnings review
Topline Surges, But Calendar Shift Masks True Run-Rate
Coca-Cola started 2026 with aggressive double-digit growth across the board: Net Revenues grew 12% and Comparable EPS jumped 18%. However, this massive acceleration was heavily flattered by six extra days in the quarter, which pushed concentrate sales 5 points ahead of actual unit case volume. Stripping away the calendar noise, underlying demand remains healthy with unit case volume up 3%. Margin expansion is intact, but glaring weakness in the Asia Pacific region proves that global consumers remain under pressure. FY26 guidance remains intact, implying a structural deceleration in the back half of the year as the calendar shift reverses and the CCBA divestiture hits.
🐂 Bull Case
After a sluggish 2025 plagued by consumer pushback, North America delivered a powerful 4% volume growth and a 20% surge in operating income. The consumer base appears to be normalizing.
Comparable operating margin expanded to 34.5% from 33.8%, proving the company can successfully offset higher input costs and increased marketing through organic revenue growth and cost discipline.
🐻 Bear Case
Despite 5% volume growth, Asia Pacific operating income fell 14%. The company was forced to slash price/mix by 6% to maintain volume, highlighting severe consumer stress in the region.
Six extra days generated a massive one-time lift to Q1 sales. This will fully reverse in Q4, guaranteeing a severe deceleration in late-year reported metrics.
⚖️ Verdict: ⚪
Cautiously Bullish. Coca-Cola's core pricing power and volume recovery in North America are impressive. However, the artificial calendar boost and the alarming profit contraction in Asia Pacific warrant a tempered outlook.
Key Themes
Asia Pacific Profitability Reversing
A glaring contradiction to the positive global narrative is the Asia Pacific segment. While unit case volume grew a healthy 5%, price/mix plummeted 6% due to aggressive affordability initiatives and unfavorable mix. This resulted in a 14% collapse in reported operating income for the segment. This macro indicator reveals a challenging environment where regional volume must be bought at the heavy expense of margins.
North America Resurgence
Following a choppy 2025 marked by Hispanic consumer pushback and targeted weakness, North America is Reversing its prior slump. Unit volume grew 4%, driven by Trademark Coca-Cola and water/sports drinks. More importantly, operating income surged 20%, proving the segment can re-accelerate volume without sacrificing its premium margin profile.
Calendar Shift Distorts Growth Trajectory
Current quarter results are artificially inflated by six additional days in the reporting calendar. This drove concentrate sales 5 points ahead of unit case volume. This ensures a Decelerating trend indicator for Q4, which will face an equal and opposite six-day headwind, making full-year linearity highly skewed.
Precision Revenue Growth Management
The company is Accelerating its packaging mix strategies to balance macro consumer constraints. Expansion of single-serve mini-cans in North America and ultra-lightweight bottles in India and South Africa successfully drove volume while protecting unit economics and averting the margin destruction seen in Asia Pacific.
AI and Digital Marketing Execution
Leveraging technology for localized marketing is paying off. The company deployed an AI-enabled Chinese New Year campaign allowing personalized digital portraits, which directly supported China's volume growth. This digital-first approach to culturally meaningful occasions (including Ramadan and Carnival) is successfully increasing weekly active drinkers.
Impending Divestiture Headwinds
The pending sale of Coca-Cola Beverages Africa (CCBA) remains a structural overhang. Management expects it to close in the second half of 2026, creating a ~4% headwind to comparable net revenues and a ~1% headwind to EPS. This guarantees Decelerating reported growth in H2 2026.
Other KPIs
Reversing the massively negative FCF seen in 25Q1 (which was artificially depressed by a $6.1 billion fairlife contingent payment). Operating cash flow was $2.0 billion. The balance sheet remains highly liquid, supporting $2.28 billion in Q1 dividend payments and $477 million in treasury stock purchases.
Surged 62% YoY despite a 1% decline in price/mix and the negative impact of refranchising. Comparable currency neutral operating income grew 53%, driven by intense cost management and organic revenue growth. This highlights exceptional operational leverage in the remaining company-owned bottling assets.
Guidance
Stable. Unchanged from prior quarters. Given the 10% organic growth in Q1 (aided by the extra days), maintaining the 4-5% full-year target implies a steep deceleration in the remaining quarters.
Accelerating versus the ~3% comparable EPS growth delivered in FY25. The outlook includes an approximate 3% currency tailwind and a 1% structural headwind from M&A. This reflects strong underlying operating leverage despite topline normalization.
Stable. Represents a healthy cash conversion profile, consisting of $14.4 billion in operating cash flow minus $2.2 billion in capital expenditures.
Decelerating. Management anticipates a 1% currency tailwind offset by a 1% headwind from acquisitions and divestitures. Without the 6-day calendar benefit of Q1, headline revenue growth will drop significantly in Q2.
Key Questions
Asia Pacific Margin Strategy
With price/mix down 6% and operating income dropping 14% in Asia Pacific, how long is management willing to sacrifice margins to stimulate unit volume in the region? Is this a permanent rebasing of regional profitability?
Calendar Shift Payback
Q1 benefited from 6 extra days, which will completely reverse in Q4. How should investors model the operational deleverage in Q4 when fixed costs remain but 6 days of concentrate sales disappear?
CCBA Divestiture Dilution
Assuming the Coca-Cola Beverages Africa sale closes in H2 2026 as planned, what is the exact margin profile impact on the consolidated business, and how will the cash proceeds be allocated?